Company intelligence / Profile preview
Edison Oncology
- Ownership
- Private
- Development stage
- Other
Overview
Edison Oncology is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for cancer, particularly for patients with high unmet needs. The company's primary focus is on its lead candidate, EO1001, a potent, irreversible, and brain-penetrant pan-ErbB kinase inhibitor. EO1001 is designed to target EGFR, HER2, and HER4, and is currently being evaluated in Phase 2 clinical trials for the treatment of glioblastoma multiforme and brain metastases. By focusing on small molecules with superior blood-brain barrier penetration, Edison Oncology aims to address difficult-to-treat central nervous system malignancies.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Edison Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Edison Oncology.